Additional studies by Sasikumar et al (15) concluded that 68GA PSMA-11 can be thought of as a potentially useful imaging tool in the evaluation of brain lesions, as radiotracers targeting the enzyme PSMA could potentially target the neovasculature of brain tumors. This evidence concerns the gene FOLH1 and brain neoplasm.